OSR Holdings, Inc.

Nasdaq:OSRHNasdaq:OSRHW

Surgical & Medical Instruments & Apparatus·BELLEVUE, WA

CEO

Hwang Kuk Hyoun

Summary Financials

Revenue

—

Adj. EBITDA

—

Net Income

$403,780

FY 2024

EPS (Diluted)

$0.05

FY 2024

Stock Price

$0.44

-1.4%

2026-03-20

52W Range

$0.38 – $4.33

P/E Ratio

8.7x

Market Cap

$11.2M

Cash

$15,419

FY 2024

Total Debt

$2.0M

FY 2023

Net Debt

$2.0M

FY 2023

Enterprise Value

$13.2M

Debt / EBITDA

—

EV / EBITDA

—

Employees

—

Revenue

—

Adj. EBITDA

—

Net Income

$403,780

FY 2024

EPS (Diluted)

$0.05

FY 2024

Stock Price

$0.44

-1.4%

2026-03-20

52W Range

$0.38 – $4.33

P/E Ratio

8.7x

Market Cap

$11.2M

Cash

$15,419

FY 2024

Total Debt

$2.0M

FY 2023

Net Debt

$2.0M

FY 2023

Enterprise Value

$13.2M

Debt / EBITDA

—

EV / EBITDA

—

Employees

—